ArticleCancer gene therapy2006

IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro.

L Vujanovic et al.PubMed ↗Publisher ↗

No numbers read from the abstract.